Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
17°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novavax Inc
(NQ:
NVAX
)
8.040
-0.020 (-0.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
3
4
5
6
7
8
9
...
60
61
Next >
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
March 07, 2024
Could these biotech companies still win in the vaccine market and beyond?
Via
The Motley Fool
The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
March 06, 2024
Explore the ups and downs of 3 meme stocks: Imperial Petroleum, Novavax and MicroCloud, as they navigate market challenges and speculation.
Via
InvestorPlace
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
March 05, 2024
The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.
Via
InvestorPlace
Exit Alert: 3 Overhyped Stocks With Weak Fundamentals
March 05, 2024
These are overhyped stocks to sell as they represent companies with weak fundamentals and prospects of cash burn.
Via
InvestorPlace
Is Novavax a Buy Now?
March 04, 2024
The stock has dropped 98% over the past three years.
Via
The Motley Fool
Novavax's Earnings Outlook
February 27, 2024
Via
Benzinga
Has Novavax Just Solved Its Biggest Problem?
February 27, 2024
The biotech company recently settled a dispute with a major customer.
Via
The Motley Fool
Better Bull Market Buy: Novavax vs. Pfizer
February 22, 2024
Bull markets usually favor stocks with promising growth prospects.
Via
The Motley Fool
Where Will Novavax Be in 10 Years?
February 15, 2024
Without any windfalls on the horizon, times are dire for this biotech.
Via
The Motley Fool
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
March 01, 2024
Can the stock's recent rally continue?
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 28, 2024
Via
Benzinga
Why Is Advance Auto Parts (AAP) Stock Trending Today?
February 28, 2024
Advance Auto Parts stock is up on Wednesday even after posting EPS and revenue misses in its earnings report for the fourth quarter of 2023.
Via
InvestorPlace
Why Is COVID-19 Vaccine Maker Novavax Stock Plunging On Wednesday?
February 28, 2024
Novavax reports Q4 2023 revenue of $291 million, missing consensus. Restructuring brings 30% workforce reduction. Anticipates COVID-19-Influenza combo vaccine Phase 3 in H2 2024. FY 2024 revenue...
Via
Benzinga
Exposures
COVID-19
NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today
February 28, 2024
Novavax stock is falling hard on Wednesday as NVAX investors react to it missing estimates for Q4 and posting weak guidance for 2024!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 28, 2024
Via
Benzinga
Earnings Scheduled For February 28, 2024
February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
Via
Benzinga
Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today
February 27, 2024
The U.S. indices were mixed with the S&P 500 rising by nearly 0.2% to 5,078.18 and the Dow Jones Industrial Average falling by 0.25% to 38,972.41.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Exploring Stocks with High Short Interest: INBS, BLNK, BYND, NVAX, PLUG
February 27, 2024
Via
AB Newswire
Topics
Electric Vehicles
Exposures
COVID-19
Electric Vehicles
Novavax’s dispute resolution and upcoming earnings call
February 23, 2024
Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.
Via
MarketBeat
Topics
Earnings
Exposures
COVID-19
Financial
12 Health Care Stocks Moving In Thursday's Intraday Session
February 22, 2024
Via
Benzinga
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 22, 2024
Shares of Etsy, Inc.
Via
Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
February 22, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Morgan Stanley Is Pounding the Table on DoorDash (DASH) Stock
February 22, 2024
DoorDash stock is rising higher on Thursday after Morgan Stanley upgraded DASH shares and increased their price target for them.
Via
InvestorPlace
Morgan Stanley Issues a Warning on Rivian (RIVN) Stock
February 22, 2024
Rivian stock is falling hard on Friday as RIVN investors react to a warning from Morgan Stanley and a weak EV production guidance for 2024.
Via
InvestorPlace
What's Going On With Novavax Stock Today?
February 22, 2024
Novavax said it reached a settlement with Gavi related to the 2021 advance purchase agreement for Novavax's prototype COVID-19 vaccine. The agreement brings the pending arbitration related to the...
Via
Benzinga
Exposures
COVID-19
NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute
February 22, 2024
Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi.
Via
InvestorPlace
Exposures
COVID-19
Get Rich Quick With These 3 Stocks to Buy Now
February 15, 2024
Although these market ideas are extremely speculative, their upcoming catalysts could make them stocks to buy now.
Via
InvestorPlace
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
February 11, 2024
Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
60
61
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.